Overdrive pacing as treatment of sotalol-induced ventricular tachyarrhythmias (torsade de pointes)

Acta Medica Scandinavica. Supplementum
K J TöttermanT Pellinen

Abstract

Four patients with ventricular arrhythmias due to sotalol intoxication were successfully treated with overdrive pacing. In three patients the reason for sotalol overdose was a suicidal attempt and in the fourth patient the reason was unknown. In all cases a prolongation of the Q-T interval was seen, which is a typical feature of sotalol overdose. Other features of beta-blocker intoxication like bradycardia were found in all patients and hypotension in two patients. Three of four patients received lidocaine, but with no effect on multiple ventricular premature beats (VPB) or ventricular tachycardia (VT) of "torsade de pointes"-type. Overdrive pacing abolished immediately VPBs and VTs in three patients, and in the fourth patient there was apparent decrease in dysrhythmia. Temporary overdrive pacing is suggested as treatment of ventricular arrhythmias in association with prolonged Q-T interval caused by overdose of sotalol.

References

May 5, 1979·British Medical Journal·E ElonenR Kala
Aug 1, 1979·The American Journal of Cardiology·S SclarovksyJ Agmon
Nov 8, 1979·The New England Journal of Medicine·A J GreensponS F Schaal
May 1, 1978·American Heart Journal·P O EttingerT J Regan
Feb 1, 1976·British Heart Journal·D M Krikler, P V Curry
Jul 17, 1976·British Medical Journal·D E Ward, B Jones
Jun 1, 1981·The American Journal of Cardiology·M M KhanA A Adgey
Jan 1, 1981·European Journal of Clinical Pharmacology·P J NeuvonenM Laakso
May 1, 1981·Postgraduate Medical Journal·A KontopoulosP Metaxas

❮ Previous
Next ❯

Citations

Apr 21, 2020·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Joe-Anthony RotellaAnselm Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

The Canadian Journal of Cardiology
Satoshi KurisuToshiyuki Aokage
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
J Bathen, S Madsen
Intensive Care Medicine
F AlderfliegelR J Kahn
© 2021 Meta ULC. All rights reserved